FDA approval sees Orthocell's Remplir enter multi-billion dollar US nerve market

By Proactive Investors / April 07, 2025 / www.youtube.com / Article Link


Orthocell Ltd chairman John van der Wielen talked with Proactive about the company receiving FDA clearance for its nerve repair ...

Recent News

AOCE and WB boost gold targets for 2025 significantly

November 10, 2025 / www.canadianminingreport.com

Gold and silver price ETFs see major net outflows

November 04, 2025 / canadianminingreport.com

Gold stocks decline by less than metal price

November 04, 2025 / www.canadianminingreport.com

A shift to the later stages of gold and silver bull markets

October 27, 2025 / www.canadianminingreport.com

Gold stocks plunge on metal drop

October 27, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok